ANTIPARASITIC DRUGS MARKET ANALYSIS

Antiparasitic Drugs Market, By Product Type (Anthelmintics (Anticestodal Drugs, Antitrematodal Drugs, and Antinematodal Drugs) Antiprotozoal Agents (Antimalarials Agents Antibabesial Agents, Antiamoebic Agents, and Others (Trypanocidal Agents, Antileishmanial Agents, etc.)), Ectoparasiticide (Antiscabietic Agents and Pediculicides)), By Route Of Administration (Oral, Injectable, and Topical), By Application (Human Health, Animal Health, Crop Health) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jun 2023
Code : CMI3782
Pages :212
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Antiparasitic Drugs Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global antiparasitic drugs market over the forecast period, as in 2022-2023 every two minutes, a child dies of malaria. And each year, more than 200 Billion new cases of the disease are reported globally. Malaria remains a threat to the U.S. travellers, the military, and to the U.S. citizens living abroad. Prevention messages need to be reinforced, but global efforts to control or eliminate the disease help reduce the risk for everyone. For that Co-implement the event by U.S. President’s Malaria Initiative (PMI), led by The United States Agency for International Development (USAID) is organized.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa